Clinical Trial Update: Effect of F2695 on Functional Recovery After Ischemic Stroke [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating F2695 for functional recovery after ischemic stroke has completed; the update notes completion of the study but does not include resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• F2695

Snippet

Sponsor: Pierre Fabre Medicament | Conditions: Ischemic Stroke | Phase 3 | Status: COMPLETED